Stanford Center for Law and the Biosciences Podcast Series Stanford Law School, Center for Law and the Biosciences
-
- Наука
Examining the impact of biotech discoveries on society and the law's role in shaping that impact.
-
fMRI Lie-Detection, Pay-to-Delay Settlements, Enhancement Technologies.
Hank Greely, Jake Sherkow, and Matt Lamkin discuss fMRI lie-detection services, pay-to-delay settlements between branded pharmaceutical and generics companies, and the arguments against increased regulation of enhancement technologies.
-
Biosimilars, Brain Myths, Orphan Drugs, and Ebola
Hank Greely, Patti Zettler, Dmitry Karshtedt, and Stephanie Bair discuss new developments related to the Biosimilars Act and FDA's orphan drug program, the policy implications of brain myths, and the current Ebola crisis.
-
Mini-Podcast with Anna Laakman.
Anna Laakman from Lewis and Clark law school discusses her recent work with Hank Greely.
-
Right to Try, Heart Valve Patents, GMO Labelling, and Neuroscience and Johnny Cash
Hank Greely, Patti Zettler, Jake Sherkow, and Malia McPherson discuss Right to Try laws, Heart Valve Patents, GMO Labelling, and Neuroscience and Johnny Cash.
-
Zohydro, Ebola, Biosimilars, and Ninth Circuit En Banc Decision
Hank Greely, Patti Zettler, and Jake Sherkow discuss the Zohydro litigation, Ebola, Biosimilars, and the Ninth Circuit's recent en banc decision.
-
Myriad Genetics, Whole Genome Sequencing, Tooth Whitening and Antitrust, Mitochondrial Transfer, and Alzheimer's Testing
Hank Greely, Patti Zettler, and Jake Sherkow discuss the Myriad Genetics case, the inaccuracies of whole genome sequencing and Alzheimer's testing, tooth whitening and antitrust, and the ethics of mitochondrial transfer.